These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7543311)

  • 41. Can asymptomatic patients with a supratherapeutic international normalized ratio be safely treated as outpatients?
    Levine M; Ruha AM; Goldstein JN
    Ann Emerg Med; 2012 Apr; 59(4):318-20. PubMed ID: 21867663
    [No Abstract]   [Full Text] [Related]  

  • 42. [A case of acute pancreatitis induced by interferon therapy for chronic hepatitis C].
    Motoo Y
    Nihon Shokakibyo Gakkai Zasshi; 1997 Aug; 94(8):572. PubMed ID: 9333656
    [No Abstract]   [Full Text] [Related]  

  • 43. Current state of interferon therapy for chronic hepatitis C.
    Iino S; Hino K; Yasuda K
    Intervirology; 1994; 37(2):87-100. PubMed ID: 7529222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin K2 for the reversal of warfarin-related coagulopathy.
    Hifumi T; Takada H; Ogawa D; Suzuki K; Hamaya H; Shinohara N; Abe Y; Takano K; Kawakita K; Hagiike M; Koido Y; Kuroda Y
    Am J Emerg Med; 2015 Aug; 33(8):1108.e1-3. PubMed ID: 25636520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Problems on interferon therapy of chronic hepatitis C].
    Miyaki K; Yamanaka M
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):252-8. PubMed ID: 7525801
    [No Abstract]   [Full Text] [Related]  

  • 46. Unmasking of coeliac disease on interferon treatment for hepatitis C.
    Lim EJ; Watson K
    Intern Med J; 2010 Jan; 40(1):85-7. PubMed ID: 20561373
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
    Abe Y; Ueda T; Kato T; Kohli Y
    Nihon Rinsho; 1994 Jul; 52(7):1817-22. PubMed ID: 7521424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Warfarin potentiation with bezafibrate.
    Beringer TR
    Postgrad Med J; 1997 Oct; 73(864):657-8. PubMed ID: 9497982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
    Mochida S; Ohnishi K; Matsuo S; Kakihara K; Fujiwara K
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interferon therapy of hepatitis C].
    Furuta S; Kiyosawa K
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):230-4. PubMed ID: 7525799
    [No Abstract]   [Full Text] [Related]  

  • 51. Initiation of methamphetamine abuse during interferon treatment.
    Lampinen TM; Greatheart MS; Schilder AJ; Kowdley K
    Am J Psychiatry; 2007 Sep; 164(9):1439. PubMed ID: 17728435
    [No Abstract]   [Full Text] [Related]  

  • 52. Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection.
    Simsek H; Savas C; Akkiz H; Telatar H
    Dermatology; 1996; 193(1):65-6. PubMed ID: 8864627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful interferon treatment for lichen planus associated with chronic active hepatitis due to hepatitis C virus infection.
    Lapidoth M; Arber N; Ben-Amitai D; Hagler J
    Acta Derm Venereol; 1997 Mar; 77(2):171-2. PubMed ID: 9111844
    [No Abstract]   [Full Text] [Related]  

  • 54. Warfarin therapy. 2.
    Deykin D
    N Engl J Med; 1970 Oct; 283(15):801-3. PubMed ID: 4917271
    [No Abstract]   [Full Text] [Related]  

  • 55. Autoimmune disorders associated with hepatitis C.
    Marcellin P; Benhamou JP
    Prog Liver Dis; 1995; 13():247-67. PubMed ID: 9224505
    [No Abstract]   [Full Text] [Related]  

  • 56. Prothrombin Complex Concentrates Use in Intracerebral Hemorrhage.
    Poli S; Härtig F; Selim MH; Molina CA; Dowlatshahi D
    Stroke; 2017 Sep; 48(9):2644-2646. PubMed ID: 28784920
    [No Abstract]   [Full Text] [Related]  

  • 57. Complications associated with warfarin prophylaxis in total knee arthroplasty.
    Sutherland CJ; Schurman JR
    Clin Orthop Relat Res; 1987 Jun; (219):158-62. PubMed ID: 3581566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perceptions about time for normalization of international normalized ratio in patients requiring acute warfarin reversal when using fresh-frozen plasma.
    Jones CA; Petrozzino JJ; Hoesche J; Krol EM; Freeman K
    Am J Emerg Med; 2013 May; 31(5):878-9. PubMed ID: 23478117
    [No Abstract]   [Full Text] [Related]  

  • 59. Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir.
    Bernardeschi C; Valeyrie-Allanore L; Ortonne N; Gressier L; Wallet-Faber N; Bernard PH; Hezode C; Duclos-Vallée JC; Samuel D; Mallet V; Pol S; Milpied B; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):143-6. PubMed ID: 25187266
    [No Abstract]   [Full Text] [Related]  

  • 60. The activated coagulation time of whole blood as a routine pre-operative sceening test.
    Hattersley PG
    Calif Med; 1971 May; 114(5):15-8. PubMed ID: 5087876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.